{"product_id":"timolol-0-5-ophthalmic-gel-topical-ointment","title":"Timolol 0.5% Ophthalmic Gel Topical Ointment","description":"\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 72266-200-01\u003c\/p\u003e\n\u003ch3\u003eTimolol Maleate Ophthalmic Gel Forming Solution 0.5%, 5 mL — Fosun Pharma\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActive ingredient\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTimolol maleate 6.8 mg\/mL (equivalent to timolol 5 mg\/mL, 0.5%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage form\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOphthalmic gel-forming solution, sterile, isotonic, buffered; gels upon contact with the tear film (preserved with benzododecinium bromide 0.012%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRoute\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOphthalmic (topical)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSize\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5 mL dropper bottle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDistributed by Fosun Pharma USA Inc.; made in India\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNDC\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e72266-200-01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch4\u003eIndications and Usage\u003c\/h4\u003e\n\u003cp\u003eIndicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.\u003c\/p\u003e\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eOne drop in the affected eye(s) once daily. Invert the closed container and shake once before each use. If other topical ophthalmic medications are used concomitantly, administer them at least 10 minutes before this product. Dosages above one drop of 0.5% once daily have not been studied. Concomitant use of two topical beta-blockers is not recommended. Has not been studied in patients wearing contact lenses.\u003c\/p\u003e\n\u003ch4\u003eWarnings and Precautions\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eSystemically absorbed; may cause the same cardiac and respiratory reactions as systemic beta-blockers, including death from bronchospasm in asthmatic patients and rarely death associated with cardiac failure\u003c\/li\u003e\n\u003cli\u003eMay precipitate cardiac failure in patients with diminished myocardial reserve; discontinue at first sign of cardiac failure\u003c\/li\u003e\n\u003cli\u003eShould generally not be used in patients with chronic obstructive pulmonary disease or bronchospastic disease\u003c\/li\u003e\n\u003cli\u003eMay mask signs of hypoglycemia in diabetic patients or signs of hyperthyroidism (e.g., tachycardia); avoid abrupt withdrawal in suspected thyrotoxicosis\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with cerebrovascular insufficiency\u003c\/li\u003e\n\u003cli\u003eBacterial keratitis has been reported with contaminated multi-dose ophthalmic containers; avoid touching the dropper tip to the eye or surrounding structures\u003c\/li\u003e\n\u003cli\u003eShould not be used alone in angle-closure glaucoma, as it has little to no effect on the pupil\u003c\/li\u003e\n\u003cli\u003ePatients with a history of atopy or severe anaphylactic reactions may be unresponsive to usual epinephrine doses used to treat anaphylaxis while on beta-blocker therapy\u003c\/li\u003e\n\u003cli\u003eMay potentiate muscle weakness in patients with myasthenia gravis or myasthenic symptoms\u003c\/li\u003e\n\u003cli\u003eTransient blurred vision (30 seconds to 5 minutes) is common following instillation and may impair the ability to drive or operate machinery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eContraindications\u003c\/h4\u003e\n\u003cp\u003eContraindicated in patients with bronchial asthma or history of bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure, cardiogenic shock, or hypersensitivity to any component of this product.\u003c\/p\u003e\n\u003ch4\u003eAdverse Reactions\u003c\/h4\u003e\n\u003cp\u003eTransient blurred vision upon instillation reported in approximately 1 in 3 patients. Burning and stinging upon instillation reported in approximately 1 in 8 patients. Other reactions (1–5% of patients) include ocular pain, conjunctivitis, discharge, foreign body sensation, itching, tearing, headache, dizziness, and upper respiratory infection.\u003c\/p\u003e\n\u003ch4\u003eStorage and Handling\u003c\/h4\u003e\n\u003cp\u003eStore at 15°C to 25°C (59°F to 77°F). Avoid freezing. Protect from light.\u003c\/p\u003e\n\u003ch4\u003eHow Supplied\u003c\/h4\u003e\n\u003cp\u003eSupplied as a colorless to nearly colorless, slightly opalescent, slightly viscous solution in a 5 mL white LDPE dispenser with a controlled drop tip and yellow polypropylene cap.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eProfessional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.\u003c\/em\u003e\u003c\/p\u003e","brand":"Fosun Pharmaceuticals","offers":[{"title":"Default Title","offer_id":53655423058285,"sku":"RX-5022","price":44.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/wholesale.dryeyerescue.com\/products\/timolol-0-5-ophthalmic-gel-topical-ointment","provider":"Dryeye Rescue Pro","version":"1.0","type":"link"}